Comparison of Enterococcus faecium Bacteremic Isolates from Hematologic and Non-hematologic Patients: Differences in Antimicrobial Resistance and Molecular Characteristics
- PMID: 29401557
- PMCID: PMC5820067
- DOI: 10.3343/alm.2018.38.3.226
Comparison of Enterococcus faecium Bacteremic Isolates from Hematologic and Non-hematologic Patients: Differences in Antimicrobial Resistance and Molecular Characteristics
Abstract
Background: Enterococcus faecium, especially vancomycin-resistant E. faecium (VREfm), is a major concern for patients with hematologic diseases. Exposure to antibiotics including fluoroquinolone, which is used as a routine prophylaxis for patients with hematologic (MH) diseases, has been reported to be a risk factor for infection with vancomycin-resistant eneterocci. We compared the characteristics of E. faecium isolates according to their vancomycin susceptibility and patient group (MH vs non-MH patients).
Methods: A total of 120 E. faecium bacteremic isolates (84 from MH and 36 from non-MH patients) were collected consecutively, and their characteristics (susceptibility, multilocus sequence type [MLST], Tn1546 type, and the presence of virulence genes and plasmids) were determined.
Results: Among the vancomycin-susceptible E. faecium (VSEfm) isolates, resistance to ampicillin (97.6% vs 61.1%) and high-level gentamicin (71.4% vs 38.9%) was significantly higher in isolates from MH patients than in those from non-MH patients. Notably, hyl, esp, and pEF1071 were present only in isolates with ampicillin resistance. Among the VREfm isolates, ST230 (33.3%) and ST17 (26.2%) were predominant in MH patients, while ST17 (61.1%) was predominant in non-MH patients. Plasmid pLG1 was more prevalent in E. faecium isolates from MH patients than in those from non-MH patients, regardless of vancomycin resistance. Transposon analysis revealed five types across all VREfm isolates.
Conclusions: The antimicrobial resistance profiles and molecular characteristics of E. faecium isolates differed according to the underlying diseases of patients within the same hospital. We hypothesize that the prophylactic use of fluoroquinolone might have an effect on these differences.
Keywords: Ampicillin; Enterococcus; Fluoroquinolone; Multilocus sequence typing; ST230; pEF1071; pLG1.
© The Korean Society for Laboratory Medicine
Conflict of interest statement
The authors declare that they have no conflicts of interest related to this study.
Figures



Similar articles
-
Prevalence of Diverse Clones of Vancomycin-Resistant Enterococcus faecium ST78 in a Chinese Hospital.Microb Drug Resist. 2016 Jun;22(4):294-300. doi: 10.1089/mdr.2015.0069. Epub 2015 Dec 10. Microb Drug Resist. 2016. PMID: 26652286
-
Clonal outbreak of ST17 multidrug-resistant Enterococcus faecium harbouring an Inc18-like::Tn1546 plasmid in a haemo-oncology ward of a Spanish hospital.J Antimicrob Chemother. 2012 Apr;67(4):832-6. doi: 10.1093/jac/dkr545. Epub 2012 Jan 6. J Antimicrob Chemother. 2012. PMID: 22228676
-
Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland.Adv Clin Exp Med. 2018 Jan;27(1):111-117. doi: 10.17219/acem/68265. Adv Clin Exp Med. 2018. PMID: 29521051
-
A molecular study regarding the spread of vanA vancomycin-resistant Enterococcus faecium in a tertiary hospital in China.J Glob Antimicrob Resist. 2022 Dec;31:270-278. doi: 10.1016/j.jgar.2022.10.010. Epub 2022 Oct 20. J Glob Antimicrob Resist. 2022. PMID: 36273808 Review.
-
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):815-25. doi: 10.1007/s10096-005-0056-0. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16374593 Review.
Cited by
-
Characteristics of Enterococcus species bloodstream infections among adults with and without onco-hematological malignancies: Experiences from the national center of Hungary.Eur J Microbiol Immunol (Bp). 2024 Mar 27;14(2):134-142. doi: 10.1556/1886.2024.00011. Print 2024 May 14. Eur J Microbiol Immunol (Bp). 2024. PMID: 38536399 Free PMC article.
-
Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis.J Antimicrob Chemother. 2024 Aug 1;79(8):1998-2007. doi: 10.1093/jac/dkae199. J Antimicrob Chemother. 2024. PMID: 38863389 Free PMC article.
-
Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.Infect Chemother. 2022 Jun;54(2):340-352. doi: 10.3947/ic.2022.0069. Infect Chemother. 2022. PMID: 35794719 Free PMC article.
-
Epidemiological profiles and pathogenicity of Vancomycin-resistant Enterococcus faecium clinical isolates in Taiwan.PeerJ. 2023 Feb 23;11:e14859. doi: 10.7717/peerj.14859. eCollection 2023. PeerJ. 2023. PMID: 36855433 Free PMC article.
-
Association of Procalcitonin with the Patient's Infection Characteristics and Prognosis after Hematopoietic Stem Cell Transplantation.Dis Markers. 2022 Sep 13;2022:9157396. doi: 10.1155/2022/9157396. eCollection 2022. Dis Markers. 2022. PMID: 36148158 Free PMC article.
References
-
- Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317. - PubMed
-
- Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med. 2001;135:484–492. - PubMed
-
- Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect. 2012;18:388–394. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous